Abstract
European consumer willingness to purchase fat-modified foods was surveyed as part of the LIPGENE study. Representative samples of consumers ( n = 5967) were interviewed in six countries (France, Great Britain, Portugal, Germany, Poland, and Italy). Of these 2025 were considered as “reporters” who indicated having at least one of: high cholesterol; high blood pressure; central obesity; and/or high blood sugar. Perceived risk from these conditions was also assessed on a 10-point scale. Principal component analysis suggested that those who perceived themselves at greater risk of conditions associated with metabolic syndrome, and those who were reporters, more frequently indicated willingness to purchase “healthy” fat-modified food products. The most preferred ‘vehicles’ for fat modification were fish and cheese. Acceptance of fat-modified fish, red meat and cheese product concepts, both standard and GM was positively associated with perceived risk of conditions associated with metabolic syndrome. Over 20% of reporters were willing to purchase GM fat-modified fish and cheese products. Our results indicate that if standard and GM fat-modified food products can be shown to ameliorate the risks presented by conditions associated with metabolic syndrome, there is a ready market for such foods.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.